Department of Medicine, Baqai Institute of Diabetology and Endocrinology, Baqai Medical University, Plot No. 1-2, II-B, Nazimabad No2, Karachi 74600, Pakistan.
Consultant Diabetes Educator, Baqai Institute of Diabetology and Endocrinology, Baqai Medical University, Plot No. 1-2, II-B, Block 2, Nazimabad, Karachi 74600, Pakistan.
Diabetes Res Clin Pract. 2020 Jul;165:108234. doi: 10.1016/j.diabres.2020.108234. Epub 2020 May 23.
To observe the effect of keeping flexible glycemic targets during fasting and tighter targets during non-fasting hours in insulin-treated people with type 2 diabetes during Ramadan.
This prospective study was conducted at Baqai Institute of Diabetology and Endocrinology in 2014. People with T2DM on split mixed insulin therapy were recruited. The pre-Ramadan education given and insulin doses were adjusted before Ramadan. 24-hour telephonic helpline service was provided to achieve pre-determined glycemic targets and minimize complications.
A total of 54 people with T2DM with a mean age of 54.65 ± 9.32 years were recruited. Mean glucose levels achieved were 183.50 ± 30.91 mg/dl and 179.20 ± 36.27 mg/dl during the day and night respectively. Mean HbA1c (p-value < 0.0001) and serum creatinine (p-value 0.0010) significantly improved at the end of Ramadan. 0.6% episodes of hypoglycemia including one major hypoglycemia while 30% of episodes of hyperglycemia were recorded. No hospitalization needed.
By keeping flexible glycemic targets during the day and tighter targets during the night, safe fasting was feasible with significant improvement in overall glycemic control without significant major complications.
观察在斋月期间,对接受胰岛素治疗的 2 型糖尿病患者,白天保持灵活的血糖目标,夜间保持更严格的血糖目标的效果。
本前瞻性研究于 2014 年在巴盖糖尿病和内分泌学研究所进行。招募接受分餐混合胰岛素治疗的 2 型糖尿病患者。在斋月前进行教育并调整胰岛素剂量。提供 24 小时电话咨询服务,以达到预定的血糖目标并最大程度减少并发症。
共招募了 54 名年龄平均为 54.65 ± 9.32 岁的 2 型糖尿病患者。白天和夜间的平均血糖水平分别为 183.50 ± 30.91mg/dl 和 179.20 ± 36.27mg/dl。平均 HbA1c(p 值<0.0001)和血清肌酐(p 值 0.0010)在斋月结束时显著改善。记录到 0.6%的低血糖发作,包括 1 次严重低血糖,而 30%的高血糖发作。无需住院治疗。
通过白天保持灵活的血糖目标,夜间保持更严格的血糖目标,可以安全禁食,总体血糖控制显著改善,且无明显重大并发症。